Quantcast

Latest Artificial pancreas Stories

2014-09-29 12:29:56

The company's distinctive dual strategy, devised to help it penetrate developing and developed regions, has fuelled its success LONDON, Sept. 29, 2014 /PRNewswire/ -- Based on its recent analysis of the therapeutic proteins market, Frost & Sullivan recognises ADOCIA with the 2014 European Frost & Sullivan Award for Technology Innovation Leadership. By adopting a flexible business model that promotes partnerships and collaboration with major players in the pharmaceutical industry,...

2014-09-16 08:31:56

--New Collaboration will Increase Data Available to Artificial Pancreas Researchers -- NEW YORK and SAN FRANCISCO, Sept. 16, 2014 /PRNewswire-USNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, and Tidepool (TM), a Silicon Valley-based non-profit organization committed to reducing the burden of T1D, announced a partnership supported by JDRF funding for data access technology for people with T1D who use insulin pumps and...

2014-09-10 08:29:58

ROSH HA-AYIN, Israel, September 10, 2014 /PRNewswire/ -- Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ssAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D). The two-year study, which will enroll eight participants at Uppsala University Hospital in Sweden, will evaluate the safety, survival and function of implanted human islets...

2014-09-04 23:02:56

Transparency Market Research published a new report "Global Continuous Glucose Monitoring Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Albany, New York (PRWEB) September 04, 2014 Continuous glucose monitoring devices are smart, tiny automated machines that provide a wide range of information about a patient’s fluctuating blood glucose levels such as the frequency, magnitude, direction, duration and causes of the...

2014-09-03 08:35:26

- FreeStyle Libre System eliminates routine finger pricks for glucose measurements1 and requires no finger pricks for calibration ABBOTT PARK, Ill., Sept. 3, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has received CE Mark (Conformite Europeenne) for its FreeStyle(®) Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for people with diabetes. The system eliminates the need for routine finger pricks(1), reading glucose levels through a...

2014-08-12 12:28:18

Company's Network and Technology Enable Trial of Artificial Pancreas in California NEW YORK, Aug. 12, 2014 /PRNewswire/ -- Kids and teens with Type 1 diabetes are swimming, rock climbing, hiking and playing various field sports in the redwoods of the Santa Cruz Mountains - all while testing a device that automatically measures their blood sugar and determines how much insulin they'll need. Using Verizon's network technology, campers aged 7 to 17 are participating in a clinical...

2014-08-04 12:35:07

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: U.S. Glucose Testing Markets http://www.reportbuyer.com/pharma_healthcare/diagnostics/u_s_glucose_testing_markets.html U.S. glucose testing is undergoing a significant transition, driven by new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, several segments of the market, such...

2014-08-04 12:34:38

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: World Glucose Self-Testing Markets http://www.reportbuyer.com/pharma_healthcare/diseases/diabetes/world_glucose_self_testing_markets.html The worldwide incidence of diabetes is dramatically increasing, and it is estimated that 439 million people will have developed the disease by 2030. As such, the global market for blood glucose self-testing products is undergoing a significant transition...

type-1 diabetes
2014-08-01 02:00:43

Susan Gammon, Ph.D., Sanford-Burnham Medical Research Institute A new study by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has found that a peptide called caerulein can convert existing cells in the pancreas into those cells destroyed in type 1 diabetes—insulin-producing beta cells. The study, published online July 31 in Cell Death and Disease, suggests a new approach to treating the estimated 3 million people in the U.S., and over 300 million worldwide,...

2014-07-30 16:28:55

-- JDRF Calls for CGM Medicare Coverage to Help Improve Health Outcomes Among Seniors with T1D and Advance an Artificial Pancreas -- WASHINGTON, July 30, 2014 /PRNewswire-USNewswire/ -- Today U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), Co-chairs of the Senate Diabetes Caucus, introduced legislation to ensure that seniors with type 1 diabetes (T1D) who are Medicare eligible have access to continuous glucose monitors (CGM) as prescribed by their physicians. The...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'